English  |  正體中文  |  简体中文  |  Items with full text/Total items : 17938/22957 (78%)
Visitors : 7391945      Online Users : 286
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    Please use this identifier to cite or link to this item: https://ir.csmu.edu.tw:8080/ir/handle/310902500/23607


    Title: Associations of Chinese Herbal Medicine Usage with Risk of Dementia in Patients with Parkinson's Disease: A Population-Based, Nested Case-Control Study
    Authors: Liang, YT;Lin, CY;Wang, YH;Chou, HH;Wei, JCC
    Keywords: dementia;Parkinson' s disease;Traditional Chinese Medicine;case– control study;Chinese herbal medicine
    Date: 2021
    Issue Date: 2022-08-05T09:40:01Z (UTC)
    Publisher: MARY ANN LIEBERT, INC
    ISSN: 1075-5535
    Abstract: Background: Patients who have Parkinson's disease (PD) comorbid with dementia is common. With the prolonged life expectancy, dementia is gradually becoming prevalent and affects most patients' life qualities. However, the efficacy of current treatments in dementia of PD is limited. Previous studies indicated the potential roles of Chinese herbal medicine (CHM) in treating dementia, yet the correlation between CHM usage and risk of dementia in PD patients is unclear. Methods: This case-control study was nested within a National Health Insurance database of patients over 50 years with newly diagnosed PD from year 2000 to 2010. Among these PD patients, dementia and nondementia groups were discussed, respectively, in terms of the duration of taking CHM (>= 90 vs. <90 days), age (50-64 vs. >= 65 years) and gender. Results: The risk of dementia in patients with PD is lower in CHM users compared with non-CHM users, especially in those taking CHM for more than 90 days (adjusted odds ratio [aOR] 0.58; 95% confidence interval [95% CI] 0.39-0.87). The use of CHM was significantly related to the lower risk of dementia in the subgroups of patients with age >= 65 years for CHM usage <90 days (aOR 0.68; 95% CI 0.53-0.88), patients with age >= 65 years for CHM usage >= 90 days (aOR 0.63; 95% CI 0.42-0.94), female patients using CHM for >= 90 days (aOR 0.43; 95% CI 0.22-0.84), and male patients using CHM for <90 days (aOR 0.62; 95% CI 0.43-0.88). Conclusions: The authors demonstrated the association of CHM usage with lower risk of dementia in patients with PD, especially in women with the usage of CHM for more than 90 days. Since no arbitrary causal conclusions could be drawn from retrospective cohort studies, the finding in this study could be used to generate a hypothesis for a subsequent design of prospective longitudinal study.
    URI: http://dx.doi.org/10.1089/acm.2020.0422
    https://www.webofscience.com/wos/woscc/full-record/WOS:000649514200001
    https://ir.csmu.edu.tw:8080/handle/310902500/23607
    Relation: JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE ,2021,v27,issue 7, P606-612
    Appears in Collections:[中山醫學大學研究成果] 期刊論文

    Files in This Item:

    File Description SizeFormat
    index.html0KbHTML190View/Open


    SFX Query

    All items in CSMUIR are protected by copyright, with all rights reserved.


    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback